Mixed infection with multiple Salmonella serotypes in the same patient is an unusual fi nding. We present a case of enteric fever in which both Salmonella Typhi and Salmonella Paratyphi A were isolated from the blood of a patient traveling from India.
nteric fever is an infectious disease of developing countries caused by Salmonella serotypes belonging to Salmonella enterica subspecies enterica . There are two forms of the disease: typhoid fever caused by serotype Typhi and paratyphoid fever caused by serotypes Paratyphi A, B, and C. Of the two, typhoid fever is the commoner and more severe condition. 1 Enteric fever in developed countries is still confi ned to the returning traveler or contacts of patients and often presents as a prolonged fever with or without other systemic symptoms. Bacteriological confi rmation of the disease rests on isolation of the organism from blood and less frequently from stool or urine. 2 The antimicrobial of choice is ciprofl oxacin, although increasing resistance has been reported particularly from the Indian subcontinent. 3 We present a case of enteric fever caused by a mixed infection with Salmonella Typhi and Salmonella Paratyphi A in a healthy woman traveling from India.
Case Report
An 81-year-old woman, a resident of India traveling to the UK on holiday, presented with a history of fever, headache, and vomiting of 1-week duration. The symptoms developed 2 days after arriving in the UK, and she does not recall any of the symptoms while in India. The fever was intermittent, with no chills or rigors, and was associated with episodes of vomiting, loss of appetite, and a frontal headache. The vomitus was nondescriptive and did not resemble coffee grounds. There was no history of abdominal pain or diarrhea. On examination, she was febrile with a temperature of 40°C and a pulse rate of 66/min. Her liver and spleen were not palpable.
Her admission peripheral blood total white cell count was 4. ( Table 1) were isolated from two different sets of blood cultures that were collected a few hours apart on the fi rst day of admission. Both isolates were sensitive to ciprofl oxacin with a minimum inhibitory concentration (MIC) of 0.05 and 0.025 mg/L, respectively (reference Salmonella spp ciprofl oxacin MIC 90 ≤ 0.06 mg/L). 4 Concurrent stool and urine cultures did not yield Salmonella or other pathogens.
Both Salmonella isolates were sent to the reference laboratory and were confi rmed as Salmonella Typhi (phage type E1) and Salmonella Paratyphi A (phage type 1).
The patient was treated with ciprofl oxacin 750 mg orally twice daily for a total of 14 days. Defervescence was documented by the fourth day with complete recovery by the end of treatment.
Discussion

This is the fi rst report of a mixed Salmonella infection in the UK. Simultaneous infection with
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Mixed Salmonella Infections different Salmonella serotypes in the same patient is rare. Even in developing countries where the disease is endemic, published data are sparse with there being just two case reports from India. 1, 5 The exact reason for this is unclear, although it is possible that mixed infections are frequently missed particularly in developing countries due to fewer blood cultures performed on those presenting with fevers, failure to isolate the organism by culture due to prior antibiotic treatment, and overreliance on an antibody test, the Widal test, 6 which has a number of limi tations including failure to diagnose Salmonella Paratyphi A infections. Thus, this phenomenon may not be as rare as is currently believed.
On the other hand, there are reports of other concurrent mixed enteric infections with enteropathogenic Escherichia coli , 7 Campylobacter jejuni , 8 Giardia lamblia , 9 Schistosoma species, 10 and enteric fever. Salmonellae resistant to ciprofl oxacin are a growing concern. In 1998, 21% of Salmonella Typhi isolated in the UK were resistant to ciprofl oxacin. 3 In addition, the standard disk-based method of susceptibility testing does not detect Salmonellae with decreased sensitivity to ciprofl oxacin. 3 Therefore, treatment failures with ciprofl oxacin are not uncommon. In the present case, both Salmonella isolates were sensitive to ciprofl oxacin (MIC ≤ 0.06 mg/L) and the patient made a good recovery. On the contrary, such mixed infections are more likely to cause treatment failures if one of the isolates shows decreased susceptibility to ciprofl oxacin. In such situations, addition of either ceftriaxone or cefotaxime is advised.
This case report adds to the existing sparse literature an apparently rare condition and raises awareness of the possibility of mixed Salmonella infections in the same patient particularly in an era where resistance to ciprofl oxacin is a growing concern. 
